Sheeja Pullarkat, MD
Anatomic Pathology · Los Angeles, CANPI 1497793384
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $206,713 of the $252,616 with a category attached, or 81.8%. 6 manufacturers reported payments, led by Stemline Therapeutics Inc. at 45.1% of the total. Among anatomic pathology clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 208 payments — averaging $1214.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stemline Therapeutics Inc.$114K
- Blueprint Medicines Corporation$108K
- Sanofi US Services Inc.$21K
- Jazz Pharmaceuticals Inc.$4K
- EUSA Pharma (US) LLC$3K
- Recordati_rare_diseases_inc.$3K
What the payments were for
- Consulting fees$11,2134%
- Speaking & faculty fees$206,71382%
- Travel & lodging$30,97412%
- Food & beverage$3,6251%
- Education$910%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stemline Therapeutics Inc. | 94 | $113,851 |
| Blueprint Medicines Corporation | 94 | $107,968 |
| Sanofi US Services Inc. | 14 | $21,105 |
| Jazz Pharmaceuticals Inc. | 2 | $4,481 |
| EUSA Pharma (US) LLC | 2 | $2,625 |
| Recordati_rare_diseases_inc. | 2 | $2,585 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$252,616 in reported general payments places this provider in the 95th percentile of 154 anatomic pathology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other anatomic pathology in Los Angeles
- Peter TontonozLos Angeles$13.6M
- Anthony SiskLos Angeles$79K
- Michael PressLos Angeles$76K
- Dinesh RaoLos Angeles$54K
- Jonathan ZuckermanLos Angeles$24K
- Hanlin WangLos Angeles$20K
- Jianyu RaoLos Angeles$7K
- Jonathan SaidLos Angeles$6K
- Louis DubeauLos Angeles$3K
- Farres ObeidinLos Angeles$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.